Journal Article

DZNE-2020-06410

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data.

Taipale, H. ; Gomm, W.DZNE* ; Broich, K. ; Maier, W.DZNE* ; Tolppanen, A.-M. ; Tanskanen, A. ; Tiihonen, J. ; Hartikainen, S. ; Haenisch, B. (Last author)DZNE*

2018
Wiley-Blackwell Oxford [u.a.]

This record in other databases:    

Please use a persistent id in citations: doi:10.1111/jgs.15358

Abstract: To evaluate the association between regular antiepileptic drug (AED) use and incident dementia.Case-control analysis.Finnish public health register and German health insurance data.Individuals with dementia of any type (German data, N=20,325) and Alzheimer's disease (AD; Finnish data, N=70,718) were matched with up to four control persons without dementia.We analyzed the association between regular AED use and dementia. To address potential protopathic bias, a lag time of 2 years between AED use and dementia diagnosis was introduced. Odds ratios (ORs) were calculated by applying conditional logistic regression, adjusted for potential confounding factors such as comorbidities and polypharmacy.Regular AED use was more frequent in individuals with dementia than controls. Regular use of AEDs was associated with a significantly greater risk of incident dementia (adjusted OR=1.28, 95% confidence interval (CI)=1.14-1.44) and AD (adjusted OR=1.15, 95% CI=1.09-1.22) than no AED use. We also detected a trend toward greater risk of dementia with higher exposure. When AEDs with and without known cognitive adverse effects (CAEs) were compared, a significantly greater risk of dementia was observed for substances with known CAEs (dementia: OR=1.59, 95% CI=1.36-1.86; AD: OR=1.19, 95% CI=1.11-1.27).AEDs, especially those with known CAEs, may contribute to incident dementia and AD in older persons.

Keyword(s): Aged (MeSH) ; Aged, 80 and over (MeSH) ; Anticonvulsants: adverse effects (MeSH) ; Anticonvulsants: therapeutic use (MeSH) ; Case-Control Studies (MeSH) ; Cognition (MeSH) ; Comorbidity (MeSH) ; Correlation of Data (MeSH) ; Dementia: diagnosis (MeSH) ; Dementia: epidemiology (MeSH) ; Female (MeSH) ; Finland: epidemiology (MeSH) ; Geriatric Assessment: methods (MeSH) ; Germany: epidemiology (MeSH) ; Humans (MeSH) ; Insurance Claim Review: statistics & numerical data (MeSH) ; Male (MeSH) ; Registries: statistics & numerical data (MeSH) ; Risk Factors (MeSH) ; Anticonvulsants

---

Contributing Institute(s):

1. Pharmacoepidemiology in Neurodegenerative Disorders (AG Hänisch)
2. U Clinical Researchers - Bonn (U Clinical Researchers - Bonn)

Research Program(s):

1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)
2. 345 - Population Studies and Genetics (POF3-345) (POF3-345)

Appears in the scientific report 2018

---

Database coverage:
; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; IF >= 5 ; JCR ; SCOPUS ; Social Sciences Citation Index ; Web of Science Core Collection

---